Virus therapy targets Hard-to-Treat melanoma in early trial
NCT ID NCT07086105
First seen Nov 21, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This early-stage study tests a new treatment called Adze1.C, a virus designed to infect and kill cancer cells while also boosting the immune system. It is for adults with advanced melanoma that has not responded to standard therapies. The main goals are to check the treatment's safety, how well people tolerate it, and find the best dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Monash Health
NOT_YET_RECRUITINGClayton, Victoria, 3168, Australia
Contact
-
Tasman Oncology Research
RECRUITINGSouthport, Queensland, 4215, Australia
Contact
-
The Queen Elizabeth Hospital
NOT_YET_RECRUITINGAdelaide, South Australia, 5011, Australia
Contact
Conditions
Explore the condition pages connected to this study.